Virbac: TP Icap Midcap upgrades stock

(CercleFinance.com) - TP Icap Midcap announced on Tuesday that it had upgraded Virbac shares from 'Hold' to 'Buy', notably citing the stock's recent downturn.


In light of cyclical, monetary, political and geopolitical uncertainties, we believe it is worthwhile to capitalise on animal health, a defensive growth sector, the broker explains.

The broker maintains its target price unchanged at E389 (cp: E353, +2.2%).


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.